Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 30 (1), 1-50

Evidence-based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review

Affiliations
Review

Evidence-based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review

Stefano Palomba et al. Endocr Rev.

Abstract

Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2 diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin resistant, metformin was introduced in clinical practice to treat these patients also. Moreover, metformin's effect has other targets beside its insulin-sensitizing action. The present review was aimed at describing all evidence-based and potential uses of metformin in PCOS patients. In particular, we will analyze the uses of metformin not only for the treatment of all PCOS-related disturbances such as menstrual disorders, anovulatory infertility, increased abortion, or complicated pregnancy risk, hyperandrogenism, endometrial, metabolic and cardiovascular abnormalities, but also for the prevention of the syndrome.

Similar articles

See all similar articles

Cited by 65 articles

See all "Cited by" articles

MeSH terms

Feedback